GSC
TMO icon

Grey Street Capital’s Thermo Fisher Scientific TMO Stock Holding History

Grey Street Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.56M Buy
+2,684
New +$1.51M 0.21% 114

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Grey Street Capital's TMO Position: Q1 2024 in Review

Grey Street Capital opened a new position in Thermo Fisher Scientific (TMO) in Q1 2024: 2,684 shares worth $1.56M. The stake represents 0.21% of the portfolio and ranks #114 among its holdings.

2,533 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Grey Street Capital held 2,684 shares of Thermo Fisher Scientific worth $1.56M as of Q1 2024.
  • Thermo Fisher Scientific was a new Grey Street Capital position in Q1 2024.
  • Thermo Fisher Scientific made up 0.21% of Grey Street Capital's portfolio in Q1 2024, its #114 holding.
  • 2,533 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.